ALSTON & BIRD LLP for NOVO NORDISK INC.
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Implementation of Pub. L. 115-97 (H.R. 1, Tax Cuts and Jobs Act).
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARK RAYDER | — |
Budget/Appropriations BUD
Issues related to the scoring of Preventive Health Savings Act, H.R. 2584/S. 1361.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PETER J ECKRICH | — |
| JOYCE E GRESKO | — |
| ELINOR HILLER | — |
| EARL POMEROY | — |
| MARK RAYDER | — |
| EMILY A SHAW | — |
| ROBERT SIGGINS | — |
| MARILYN K YAGER | — |
Medicare/Medicaid MMM
H.R. 1530/S. 595 Treat and Reduce Obesity Act; Medicare Diabetes Prevention Program; Issues related to Medicare Part D; Issues related to International Pricing Index (IPI)/reference pricing in Medicare; H.R. 107 - related to maximum Medicaid rebates; Medicare Part D Rebate Rule; H.R.3 Lower Drug Costs Now Act of 2019; H.R. 19, Lower Costs, More Cures Act of 2019; S. 2543, Prescription Drug Pricing Reduction Act of 2019; H.R. 4906/S. 2199, Insulin Price Reduction Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PETER J ECKRICH | — |
| ELINOR HILLER | — |
| JANE LUCAS New | Special Assistant to the President, White House Office of Legislative Affairs; Principal Deputy Director, IOS-Office of Health Reform, HHS; Legislative Director, Sen. John Thune (R-SD). All lobbying activities conducted in compliance with EO 13770. |
| EARL POMEROY | — |
| MARK RAYDER | — |
| EMILY A SHAW | — |
| ROBERT SIGGINS | — |
| MARILYN K YAGER | — |
Health Issues HCR
General diabetes prevention; medication affordability and access; S. 1948/H.R. 3709, Chronic Disease Management Act; issues related to high deductible health plan pre-deductible coverage of treatments and services for chronic diseases.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PETER J ECKRICH | — |
| JOYCE E GRESKO | — |
| ELINOR HILLER | — |
| EARL POMEROY | — |
| MARK RAYDER | — |
| EMILY A SHAW | — |
| ROBERT SIGGINS | — |
| MARILYN K YAGER | — |
Pharmacy PHA
H.R. 1520 - Purple Book Continuity Act of 2019; H.R. 1503 - Orange Book Transparency Act of 2019; Issues related to importation; H.R. 4906/S. 2199, Insulin Price Reduction Act; S. 1895, Lower Health Care Costs Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELINOR HILLER | — |
| JANE LUCAS New | Special Assistant to the President, White House Office of Legislative Affairs; Principal Deputy Director, IOS-Office of Health Reform, HHS; Legislative Director, Sen. John Thune (R-SD). All lobbying activities conducted in compliance with EO 13770. |
| MARK RAYDER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.